Collectively, these data certainly support semaglutide as an efficacious treatment option in people with heart failure and preserved ejection fraction, not just in terms of improvements in symptoms and physical limitations, as we showed previously in the STEP-HFpEF program, but also now for reducing clinical events such as cardiovascular death and worsening heart failure, Kosiborod said during the presentation
Both Wegovy and Ozempic are brand names for the active ingredient semaglutide
299,300 Phase 2 trials of once weekly administration of the amylin receptor agonist, eloralintide, in adults with overweight or obesity and without type 2 diabetes have demonstrated significant weight loss, with a mean decrease in body weight ranging from 916%, compared with 0.4% in the placebo group.301 Combination therapy of amylin and semaglutide has also shown promise in weight management, with over 40% of trial participants achieving a decrease in body weight of 25%
The injection is most effective when used in conjunction with a low-calorie diet and regular exercise
As one endocrinologist at KU Leuven told Medscape: I dont think we have seen enough data to be able to say this one is far more promising than the others